Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal Analgesics for Postoperative Pain After Minimally Invasive Hysterectomy
NCT04130464Phase 4Recruiting
- Start
- Sep 2019
- Primary completion
- Sep 2026
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine hydrochloride liposomal suspension injection and ketorolac in postoperative pain (3 arms). Primary endpoint: Pain Level at 72 hours. Started Sep 2019; status: recruiting.
02
Drugs
ropivacaine hydrochloride liposomal suspension injectionketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04130464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04130464.